| SCLE | subacute cutaneous lupus erythematosus |
|---|---|
| SDC | serum digoxin concentration; Smith delay compensator; sodium deoxycholate; subacute combined degener... |
| SHN | spontaneous hemorrhagic necrosis; subacute hepatic necrosis |
| SIA | serum inhibitory activity; stress-induced analgesia; stress-induced anesthesia; subacute infectious ... |
| SMON | subacute myeloopticoneuropathy |
| subacute |
Adverse effects occurring as a result of repeated daily dosing of a chemical, or exposure to the chemical, for part of an organism's lifespan (usually not exceeding 10%). With experimental animals, the period of exposure may range from a few days to 6 months.
출처: www.bio.hw.ac.uk/edintox/glossall.htm
|
|---|---|
| subacute |
A moderate condition in terms of duration and/or severity.
출처: www.sdrpharma.com/sj.htm
|
| subacute |
A zone between acute and chronic, denoting the course of a disease.
출처: counsellingresource.com/distress/chronic/cfs/gloss...
|
| subacute |
Intermediate between acute and chronic, not quite being one or the other.
출처: www.amershamhealth.com/public/glossary/s.shtml
|
| subacute combined degeneration of spinal cord |
Degeneration of the posterior and lateral columns of the spinal column. Clinically, paresthesia, sensory ataxia, and sometimes spastic paraplegia are present. The disease is the result of pernicious
출처:
|